Orsellinic acidCAS# 480-64-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 480-64-8 | SDF | Download SDF |
| PubChem ID | 68072 | Appearance | Powder |
| Formula | C8H8O4 | M.Wt | 168.2 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2,4-dihydroxy-6-methylbenzoic acid | ||
| SMILES | CC1=CC(=CC(=C1C(=O)O)O)O | ||
| Standard InChIKey | AMKYESDOVDKZKV-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C8H8O4/c1-4-2-5(9)3-6(10)7(4)8(11)12/h2-3,9-10H,1H3,(H,11,12) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Orsellinic acid is a novel benzoquinone ring precursor for antroquinonol and 4-acetylantroquinonol B, it formed from acetyl-coenzyme Q (CoQ) and malonyl-CoA via polyketide pathway. 2. Orsellinic acid can block platelet activating factor (PAF)-mediated neuronal apoptosis without affecting G-protein coupled receptor (PAFR)-mediated neuroprotection, it can effectively attenuate PAFR-independent neuronal apoptosis. |
| Targets | Caspase | PAFR |
Orsellinic acid Dilution Calculator
Orsellinic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.9453 mL | 29.7265 mL | 59.453 mL | 118.9061 mL | 148.6326 mL |
| 5 mM | 1.1891 mL | 5.9453 mL | 11.8906 mL | 23.7812 mL | 29.7265 mL |
| 10 mM | 0.5945 mL | 2.9727 mL | 5.9453 mL | 11.8906 mL | 14.8633 mL |
| 50 mM | 0.1189 mL | 0.5945 mL | 1.1891 mL | 2.3781 mL | 2.9727 mL |
| 100 mM | 0.0595 mL | 0.2973 mL | 0.5945 mL | 1.1891 mL | 1.4863 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lecanoric acid
Catalog No.:BCN5562
CAS No.:480-56-8
- Retrorsine
Catalog No.:BCN2119
CAS No.:480-54-6
- Hydrangenol
Catalog No.:BCN5561
CAS No.:480-47-7
- Acacetin
Catalog No.:BCN5560
CAS No.:480-44-4
- Isosakuranetin
Catalog No.:BCN5559
CAS No.:480-43-3
- Naringenin
Catalog No.:BCN5558
CAS No.:480-41-1
- Chrysin
Catalog No.:BCN5557
CAS No.:480-40-0
- Pinocembrin
Catalog No.:BCN5556
CAS No.:480-39-7
- Pinostrobin
Catalog No.:BCN5555
CAS No.:480-37-5
- Linarin
Catalog No.:BCN5554
CAS No.:480-36-4
- Eugenin
Catalog No.:BCN2921
CAS No.:480-34-2
- Mellein
Catalog No.:BCN4785
CAS No.:480-33-1
- 2',4',6'-Trihydroxyacetophenone
Catalog No.:BCN3996
CAS No.:480-66-0
- Jaconine
Catalog No.:BCN2089
CAS No.:480-75-1
- Jacoline
Catalog No.:BCN2088
CAS No.:480-76-2
- Platyphylline
Catalog No.:BCN2115
CAS No.:480-78-4
- Integerrimine
Catalog No.:BCN2131
CAS No.:480-79-5
- Seneciphylline
Catalog No.:BCN5563
CAS No.:480-81-9
- Indicine
Catalog No.:BCN1995
CAS No.:480-82-0
- Echinatine
Catalog No.:BCN1968
CAS No.:480-83-1
- Retronecine
Catalog No.:BCN2034
CAS No.:480-85-3
- Retusine
Catalog No.:BCN2123
CAS No.:480-86-4
- Dicrotaline
Catalog No.:BCN2079
CAS No.:480-87-5
- Benzofuroxan
Catalog No.:BCC8852
CAS No.:480-96-6
Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.[Pubmed:17877634]
J Neurochem. 2007 Oct;103(1):88-97.
The bioactive lipid mediator platelet activating factor (PAF) is recognized as a key effecter of neuronal apoptosis, yet it is not clear whether its G-protein coupled receptor (PAFR) initiates or prevents PAF neurotoxicity. Using PAFR-/- and congenic wild-type mice, we show that PAF triggers caspase-3/7 activity and neuronal death in PAFR-/- but not PAFR+/+ cerebellar granule neurons. Restoring receptor expression by recombinant adenoviral infection protected cells from PAF challenge. Neuronal death was not mediated by nitric oxide or N-methyl-d-aspartate receptor signaling given that N-nitro-l-arginine methyl ester and MK-801 did not inhibit PAF-induced neuronal loss in PAFR-/- neurons. To intervene in PAFR-independent neurotoxicity, the anti-apoptotic actions of three structurally distinct PAF antagonists were compared to a panel of plant and fungal benzoic acid derivatives. We found that the PAF antagonist BN 52021 but not FR 49175 or CV 3988 inhibited PAFR-independent neurotoxicity. Orsellinic acid, a fungal-derived benzoic acid, blocked PAF-mediated neuronal apoptosis without affecting PAFR-mediated neuroprotection. These findings demonstrate that PAF can transduce apoptotic death in primary neurons independently of its G-protein coupled receptor, that PAFR activation is neuroprotective, and that Orsellinic acid effectively attenuates PAFR-independent neuronal apoptosis.
Globosumones A-C, cytotoxic orsellinic acid esters from the Sonoran desert endophytic fungus Chaetomium globosum.[Pubmed:15921417]
J Nat Prod. 2005 May;68(5):724-8.
Three new esters of Orsellinic acid, globosumones A-C (1-3), and three known compounds, Orsellinic acid (4), orcinol, and trichodion (5), were isolated from Chaetomium globosum endophytic on Ephedrafasciculata (Mormon tea). The structures of the new compounds 1-3 were established spectroscopically, which included 2D NMR experiments and 1H NMR studies on Mosher's ester derivatives. All compounds were evaluated for inhibition of cell proliferation in a panel of four cancer cell lines, NCI-H460 (non-small cell lung cancer), MCF-7 (breast cancer), SF-268 (CNS glioma), and MIA Pa Ca-2 (pancreatic carcinoma), and normal human fibroblast cells (WI-38). Only globosumones A (1) and B (2) were found to be moderately active.
